15 minute read

We interview Val Petursson, Senior Director of Global Transportation at Teva Pharmaceuticals

Val Petursson, Senior Director of Global Transportation at Teva Pharmaceuticals, discusses the importance of global standardisation, advanced IT solutions, and of forming strategic partnerships when undergoing a successful logistics transformation.

TEVA PHARMACEUTICALS IS THE LARGEST GENERIC PHARMACEUTICAL COMPANY IN THE WORLD, OPERATING IN ALL REGIONS, WITH LARGE PHARMA OPERATIONS IN EUROPE, THE US, ISRAEL AND INDIA, AND COMMERCIAL PRESENCE IN MOST COUNTRIES WORLDWIDE.

ts logistic network is very large and complex, and has been undergoing an End-to-End transformation for the last six years. Val Petursson, Senior Director of Global Transportation, explains, “Teva Pharmaceuticals brings medicines to 200 million people every single day, and is the world´s largest medicine cabinet. The company’s numerous acquisitions of the previous decades resulted in a number of challenges for our Supply Chain and logistics, such as multiple IT systems in manufacturing sites and markets, different channels to market, hundreds of logistic partners, and no common global way of doing logistics.

“A major weakness was the lack of logistic intelligence i.e. globally standardised data and information on our compliance, service and cost levels. The

defined scope of logistics was too narrow, and an End-to-End approach was not taken. We are still on a journey, and we have plenty to accomplish yet, but looking at where we were six years ago, Teva has made huge leaps in globalising processes and systems, and in building strategic partnerships with the world´s most experienced logistic partners, utilising their core capabilities and knowhow to build solutions that benefit both parties long term. In doing so, we needed to look at many elements with fresh eyes from the start, sometimes referred to as ‘starting from a brownfield’.”

Defining the scope of logistics and the task at hand

Teva has dozens of its own sites and hundreds of CMO’s, and 200 million daily customers in 80 markets. Discovering the true complete cost and scope was no easy task, as it is often hidden. This brings further disadvantages when it comes to the visibility of incoming products and the suboptimised inbound warehouse operations. Val breaks logistics into three distinct legs. Leg A is the transportation of materials into the company’s manufacturing sites, while Leg B refers to the movement of the finished products from these sites into individual market DC’s. The third and final

“Teva has dozens of it’s own sites and hundreds of CMO’s, and 200 million daily customers in 80 markets”

leg, Leg C, is the logistics from the market DC’s to the final customers e.g. wholesalers, hospitals etc. Val says, “Whilst optimising in all of those buckets individually, full optimisation is only reached by connecting all three. We have to look at these legs as one cost bracket in order to unify the processes, standardise the IT systems, and design and align in detail with other Supply Chain stakeholder sites and markets.”

Logistic majority: A journey from transactional and local logistics to a globally integrated set-up with strategic partnerships

Pharma logistics is exceptionally exciting, yet much more regulated and complex than

Cold Chain as a Service® is threefold.

Our customers are leveraging their data to connect stakeholders, improve efficiency, and increase revenues.

Controlant’s solution delivers a single source of truth, providing visibility for products during transit and storage.

HARDWARE Wireless and reusable Internet of Things (IoT) loggers collect data in real-time and automatically send data to the cloud. No gateways or manual USB uploads are needed.

SOFTWARE An intelligent cloud platform delivers critical supply chain analytics and custom insights based on your companies KPI’s.

SERVICES Cost-reducing operational services optimize efficiency and substantially reduce waste.

Pay-per-shipment. Gain complete visibility and control. Learn more or try a pilot.

controlant.com contact@controlant.com North America 1.855.44.CONTROL Worldwide +354 517 0630

The ROI of real-time supply chain visibility

Real-time visibility for the temperature-controlled supply chain is universally desired by enterprises, customers, shippers, and carriers, but its bottom-line dollar value is less often discussed. That means it often remains a nice-to-have rather than a must-have. You know that complete visibility over the entire supply chain is likely to have a good effect on business, but the tendency is to regard it as an ineffable benefit that either cannot adequately be measured or that is considered too expensive or complicated as an investment.

This is an antiquated mode of thinking and it is largely inaccurate. Allowing a belief that it isn’t possible to put hard figures against the benefits of a real-time supply chain visibility program to prevent your business from implementing one is likely to put you at a significant disadvantage, both from a competitive standpoint and a business standpoint. Data can now demonstrate that having complete visibility and control over the entire supply chain can lead to exponential cost savings and ROI. Improved visibility reduces both product and operational waste. It illuminates the dark spots in the supply chain, enabling businesses to focus only on what matters, and helps drive continuous efficiency and improvement. Further, real-time visibility is tied directly to better customer service, one of the strongest competitive differentiators available.

Heads of supply chain logistics and quality managers now have a far stronger argument than ever before when it comes to convincing C-level executives to green-light buying and installing a real-time visibility solution. Through data, they can now clearly demonstrate why the short-term operational disruption involved in making the most of today’s visibility technologies can be justified.

For producers handling perishable and sensitive goods, one of the most significant challenges is maintaining products at the optimum temperatures—temperature monitoring is mission critical. This is made more challenging as products make their way through various stages of the supply chain. At each step, a slight variation in temperature conditions can lead to unsafe conditions that impact quality and integrity. The product may have been left out of refrigeration, left to sit in the sun or in a holding area for too long, or placed within a truck without palettes to optimize the airflow inside. Each lane of travel—air, road, or sea—requires different types of handoff points and each poses different risks. As the global cold chain is increasingly more complex, there has been a growing need for a trusted, secure way to document temperature and product movement endto-end in a traceable format that can satisfy the reporting requirements and data shared with stakeholders.

Supply chain resilience is becoming increasingly important because the frequency, magnitude, and costs of disruptions are increasing. Within the cold chain, problems typically happen at multiple handoff points. Today, temperature excursions account for nearly 80 percent of supply chain problems.

Climate change, increasing transportation costs, driver shortages, and other supply chain disruptions are forcing greater efficiency, not only to prevent spoilage but to maximize profitability.

Learn more or try a pilot.

controlant.com contact@controlant.com North America 1.855.44.CONTROL Worldwide +354 517 0630

other industries. These regulations are extremely strict, and as Teva’s market is enormous, with products and material moving intercontinentally and in different temperature ranges (all the way from -40°C to 15-25°C), the task to standardise its movements and processes was massive, and is still ongoing.

According to Val, many global and, in particular, fast-growing companies find themselves at some point in a situation where they discover that their legacy set-up simply isn’t scalable. Cost becomes an issue, the set-up doesn’t integrate with other IT parts of the Supply Chain, and logistics are seen as purely transactional as opposed to value-adding units. At the start of a transformation, companies will begin by being an enabler, before becoming a value-adding driver. So, how do you become faster and leaner, finding better solutions that give a competitive edge in the commercial space? Val continues, “We are now on this journey towards global standardisation and optimisation, focusing on value-adding, End to End logistics elements. We redefined our entire

operations and purpose, asking difficult questions, such as what we were good at and where we were behind. And in cases of where we were behind, we asked the question of whether we should continue doing it or ask someone else to do it for us (Insource/Outsource model). The core purpose of Teva Pharmaceuticals is to manufacture and sell pharmaceuticals. We are not a logistics company. Therefore, we strategically partner up with companies whose core function is logistics to help us on our journey.”

Strategic partnerships: Control towers (4PL concepts)

Most large companies have moved a critical part of their logistics function to logistics control towers (or 4PLs). Teva took this step in 2017 to a global scale whilst continuing to optimise and improve. Val explains, “A logistics control tower is a concept of standardisation of logistics; one global IT setup, reports, execution, and process optimisation. Usually, companies outsource control towers, which becomes, in most cases, a fundamental “The 4PL becomes an absolute core element of the logistics and valueadding for the entire Supply Chain of the company. This is a gamechanger for quality, service and cost”

“At Teva Pharmaceuticals, there is great awareness of sustainable solutions. We have taken a very clear strategic approach – we are not just following the minimal guidelines, but we want to lead the way”

Val Petursson, Senior Director of Global Transportation at Teva Pharmaceuticals

strategic partnership. The 4PL becomes an absolute core element of the logistics and value-adding for the entire Supply Chain of the company. This is a gamechanger for quality, service and cost. For us, this opened up visibility and a fact-based approach towards everything we do, ensuring fact-based conversations with our internal stakeholders.

“By going through a control tower and booking everything through one single conduit, it also allows us to see where we need to improve and where the true problems lie, so we can prioritise our projects and put the right resources on the right pain points. We went from local logistics with low visibility on compliance, quality and cost, to one global control tower set-up, which provides all the visibility we need. It is a one-stop shop, comprising everything from logistic transactions, invoicing and reporting, to project management and value-added services.”

By moving from local ownership to an external 4PL concept, Teva Pharmaceuticals changed its mindset towards forming strategic partnerships to assist its transformation; partners for transportation, warehousing, cargo protection, and not least, cargo monitoring. Val says, “We

realised more and more that, as we are not logistics experts, we needed to sign up with core service providers. We went through a long process of testing their qualities and expertise, selecting a handful of them to work with us on a strategic level. We are able to talk through any issues and learn how other companies are dealing with these problems to create solutions together that benefit us in the long run. This has been the key to the success of our transformation.”

The Covid pandemic in 2020 and 2021 was perhaps the biggest test for Teva Pharmaceuticals’ logistics function in the last six years. Val recalls, “There has been no event in the world that has influenced logistics quite as much as Covid. Almost overnight, most air capacity worldwide was down. Furthermore, the logistic pharma world experienced frequent and rapid ad hoc border closures from different countries in Europe, which caused extreme difficulties in the pharma road network in Europe.”

Val continues, “There were no passenger planes during Covid, but 80 per cent of all pharmaceuticals in the world moved at that time on these planes. With most of Teva’s airshipped products moving with

“We delivered to our 200 million people every day, despite the extreme circumstances throughout a very difficult 2020 and 2021”

“When it comes to protecting its products, Teva Pharmaceuticals has also partnered with world-leading partners”

strategic partners on cargo planes, we were only marginally impacted by this situation. Our strategic partner on road in Europe secured an uninterrupted flow of products through the very congested borders, keeping all countries healthy on critical medical supplies. Covid and, later on, Brexit caused a lot of concern within most healthcare sectors, as our pipeline is critical for them. We delivered to our 200 million people every day, despite the extreme circumstances throughout a very difficult 2020 and 2021. This would not have been the case without the strategic partnerships, and the visibility and tools at hand today.”

Monitoring solutions and protective packaging in pharma

With very strict regulations on temperature protection during transportation of pharma products, monitoring and protective solutions are vital to the industry. Both industries have advanced enormously in recent years. In

the monitoring space, Teva works with a world-leading innovative partner that provides an End-to-End realtime monitoring solution on its moving products across the world. Val says, “With this new technology, we have a 24/7 visual on all our moving products, and if they are stored at the wrong temperature or if they go missing, we receive an alert in real time, and can take appropriate mitigation action before the product is lost or damaged. This is a true gamechanger, and brings significant robustness in to our Supply Chain.”

Global Transport and Logistics

Healthcare is the logistics that makes the world a better place

Our services, facilities and transport networks comply with relevant healthcare quality standards and regulations. We act on rising demands for value-added delivery services to hospitals, care homes and pharmacies.

When it comes to protecting its products, Teva Pharmaceuticals has also partnered with world-leading partners. Val adds, “They provide equipment to keep the temperature of our products within the right range. In this way, they help us to uphold regulations by protecting the products we move. The quality and diversity of the protective products have advanced. They are more secure and definitely more protective, designed for different temperature ranges. Without those solutions, we would not be able to move pharmaceutical products in a compliant way today. They are absolute key for the industry.”

Sustainability – green footprint

The next large change in logistics will be the new regulations on carbon footprint and CO2 emissions. It is clear that cities will disallow current transportation forms in the future, raising diesel fuels taxes, as is already happening. Some might see this as a threat, but it is as a real opportunity for first movers.

Val says, “At Teva Pharmaceuticals, there is great awareness of sustainable solutions. We have taken a very clear strategic approach – we are not just following the minimal guidelines, but we want to lead the

Does your supply chain keep you up at night?

Illuminate the weak spots and proactively protect your business.

Our cost-effective Cold-Chain-as-a-Service® digital visibility platform solution delivers a single source of supply chain truth. Controlant customers are achieving improvements leading to a substantial return on investment.

Real-time temperature monitoring Product movement traceability 24/7 monitoring and response IoT management services Analytics and insights

Pay-per-shipment. Gain complete visibility and control. Learn more or try a pilot.

controlant.com contact@controlant.com North America 1.855.44.CONTROL Worldwide +354 517 0630

“At Teva Pharmaceuticals, there is great awareness of sustainable solutions. We have taken a very clear strategic approach – we are not just following the minimal guidelines, but we want to lead the way”

way. For several years, we have explored new technologies to move our products in a green way. We are evaluating a project on using drones to move products from market warehouses to the wholesalers, and we are actively working with companies which manufacture hydraulic vehicles and trucks with solar cells on their roofs. We believe that whatever we invest in this initiative, we will get back in image, goodwill, and, of course, in doing the right thing for our planet. Sustainability is carved in to the company’s core strategic mission.”

For Val, the future means continuing to harvest on Teva Pharmaceuticals’ intelligence and experience, with help from its strategic partners, as well as looking further and wider in the logistics network to optimise and improve. He concludes, “The keyword is integrated logistics, with great emphasis on IT solutions and business intelligence to improve compliance, service and cost for our customers, as well as adding value through our green solutions.”

For further information on Teva Pharmaceuticals, visit www.tevapharm.com

This article is from: